title: Hormones in pregnancy.
abstract: The endocrinology of human pregnancy involves endocrine and metabolic changes that result from physiological alterations at the boundary between mother and fetus. Progesterone and oestrogen have a great role along with other hormones. The controversies of use of progestogen and others are discussed in this chapter. Progesterone has been shown to stimulate the secretion of Th2 and reduces the secretion of Th1 cytokines which maintains pregnancy. Supportive care in early pregnancy is associated with a significant beneficial effect on pregnancy outcome. Prophylactic hormonal supplementation can be recommended for all assisted reproduction techniques cycles. Preterm labor can be prevented by the use of progestogen. The route of administration plays an important role in the drug's safety and efficacy profile in different trimesters of pregnancy. Thyroid disorders have a great impact on pregnancy outcome and needs to be monitored and treated accordingly. Method of locating review: Pubmed, scopus.
authors: Department of Obstetrics and Gynecology, Kasturba Medical College, Manipal University, Manipal, Karnataka, India.
authors: Pratap
authors: P
authors: Kumar
authors: Navneet
authors: N
authors: Magon
keywords: Oestrogen; hormones; progesterone; thyroid
references: Best Pract Res Clin Obstet Gynaecol. 2008 Apr;22(2):375-89
references: 17964858
references: Hum Reprod. 1997 Feb;12(2):387-9
references: 9070732
references: Cochrane Database Syst Rev. 2011 Oct 05;(10):CD009154
references: 21975790
references: Maturitas. 2009 Dec;65 Suppl 1:S43-6
references: 20007011
references: Med Clin North Am. 2012 Mar;96(2):235-56
references: 22443973
references: N Engl J Med. 2003 Jun 12;348(24):2379-85
references: 12802023
references: Am J Obstet Gynecol. 1973 Mar 15;115(6):759-65
references: 4688578
references: Curr Opin Obstet Gynecol. 2005 Dec;17(6):598-600
references: 16258341
references: Aust N Z J Obstet Gynaecol. 2008 Feb;48(1):58-63
references: 18275573
references: Endocr Rev. 2010 Oct;31(5):702-55
references: 20573783
references: Gynecol Obstet Invest. 2011;72(4):269-73
references: 22086108
references: Fertil Steril. 1993 May;59(5):1059-64
references: 8486174
references: J Reprod Immunol. 2011 Jun;90(1):58-66
references: 21641659
references: Ther Clin Risk Manag. 2009 Feb;5(1):55-64
references: 19436604
references: Cochrane Database Syst Rev. 2004;(3):CD004830
references: 15266541
references: Hum Reprod Update. 2012 Jul;18(4):360-73
references: 22431565
references: Eur J Obstet Gynecol Reprod Biol. 2002 Sep 10;104(2):156-9
references: 12206930
references: Cochrane Database Syst Rev. 2010 Jul 07;(7):CD007752
references: 20614463
references: J Exp Med. 2001 May 21;193(10):1199-212
references: 11369791
references: Fertil Steril. 2006 May;85(5):1550-2
references: 16603159
references: Gynecol Obstet Invest. 2004;58(2):105-8
references: 15192285
references: Cochrane Database Syst Rev. 2011 Dec 07;(12):CD005943
references: 22161393
references: J Reprod Immunol. 2011 Dec;92(1-2):103-7
references: 22032897
references: Eur J Obstet Gynecol Reprod Biol. 2011 Feb;154(2):172-6
references: 21067858